Litigation Details for CELGENE CORPORATION v. HETERO LABS LIMITED (D.N.J. 2017)

CELGENE CORPORATION v. HETERO LABS LIMITED (D.N.J. 2017)

Docket		Date Filed	2017-05-11
Court	District Court, D. New Jersey	Date Terminated	2021-08-19
Cause	35:271 Patent Infringement	Assigned To
Jury Demand	None	Referred To
Parties	CELGENE CORPORATION; HETERO USA, INC.
Patents	10,555,939; 6,045,501; 6,281,230; 6,315,720; 6,476,052; 6,555,554; 6,561,976; 6,561,977; 6,755,784; 6,869,399; 7,119,106; 7,141,018; 7,189,740; 7,393,862; 7,468,363; 7,968,569; 8,198,262; 8,315,886; 8,404,717; 8,530,498; 8,626,531; 8,648,095; 8,673,939; 8,735,428; 8,828,427; 8,927,592; 9,056,120; 9,101,621; 9,101,622; 9,993,467
Attorneys	GURPREET SINGH WALIA; MONVAN HU
Firms	Fisher Broyles LLP; Saul Ewing Arnstein & Lehr LLP
Link to Docket	External link to docket

Biologic Drugs cited in CELGENE CORPORATION v. HETERO LABS LIMITED

Details for CELGENE CORPORATION v. HETERO LABS LIMITED (D.N.J. 2017)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
0000-00-00	168	Letter	judgment of non-infringement of U.S. Patent No. 8,828,427 B2 (“’427 patent”). At the …judgment of non-infringement of U.S. Patent No. 8,828,427 (“’427 patent”); WHEREAS, on May 11…summary judgment of non-infringement of the ’427 patent (“Joint Letter concerning summary judgment…5 PageID: 4303 non-infringement of the ’427 patent by May 25, 2018 (17-3159 ECF No. 89, Text Order…summary judgment of non-infringement of the ’427 patent, and wish to join in the joint letter to be submitted	External link to document
2018-06-04	171		antibiotics, collagen, botulinum toxin, inter- Nos. 6,281,230 and 5,635,517; U.S. publication nos. 2004/ … United States Patent (10) Patent No.: … (45) Date of Patent: Sep.9,2014 (54)… U.S. PATENT DOCUMENTS Hopatcong, OH … FOREIGN PATENT DOCUMENTS ( *) Notice: Subject to	External link to document
2018-08-29	211	Statement	Evidence: • U.S. Patent No. 6,045,501 generally, including … • File History of United States Patent No. 6,045,501 …Evidence: • U.S. Patent No. 6,045,501 generally, including … • File History of U.S. Patent No. 6,045,501 at o Claims, Abstract, … • U.S. Patent No. 6,045,501:	External link to document
2018-10-05	227	Exhibits 1-15 (Part 1)	antibiotics, collagen, botulinum toxin, inter- Nos. 6,281,230 and 5,635,517; U.S. publication nos. 2004/ …Claims of U.S. Patent Nos. 8,198,262 (“the ’262 patent”), 8,673,939 (“the ’939 patent”), 8,735,428 …8,735,428 (“the ’428 patent”), and 8,828,427 (“the ’427 patent”) (collectively, “the Patents-in-Suit”). …clients. One of the patents 3 is a formulation patent. It's a very specific…): Patent Asserted Claims ’262 patent [DEFS_POM_	External link to document